comparemela.com

Latest Breaking News On - Parkside financial bank - Page 16 : comparemela.com

Keeley Teton Advisors LLC Has $8 03 Million Stock Holdings in ChampionX Co (NASDAQ:CHX)

Keeley Teton Advisors LLC lifted its holdings in shares of ChampionX Co. (NASDAQ:CHX – Free Report) by 2.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 275,029 shares of the company’s stock after acquiring an additional 5,819 shares during the quarter. ChampionX makes up […]

Cibc World Markets Corp Purchases New Position in Veeva Systems Inc (NYSE:VEEV)

Cibc World Markets Corp acquired a new stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 70,252 shares of the technology company’s stock, valued at approximately $13,525,000. Other hedge funds and other […]

Vinva Investment Management Ltd Boosts Holdings in Snowflake Inc (NYSE:SNOW)

Vinva Investment Management Ltd boosted its position in shares of Snowflake Inc. (NYSE:SNOW – Free Report) by 38.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 6,902 shares of the company’s stock after purchasing an additional 1,906 shares during the quarter. Vinva Investment Management Ltd’s holdings […]

Vinva Investment Management Ltd Boosts Holdings in Snowflake Inc (NYSE:SNOW)

Vinva Investment Management Ltd boosted its position in shares of Snowflake Inc. (NYSE:SNOW – Free Report) by 38.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 6,902 shares of the company’s stock after purchasing an additional 1,906 shares during the quarter. Vinva Investment Management Ltd’s holdings […]

Epoch Investment Partners Inc Purchases 831,199 Shares of Halozyme Therapeutics, Inc (NASDAQ:HALO)

Epoch Investment Partners Inc. raised its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 250.5% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,163,033 shares of the biopharmaceutical company’s stock after buying an additional 831,199 shares during the quarter. Epoch Investment Partners Inc.’s holdings in Halozyme Therapeutics were worth $42,986,000 […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.